Although genomic alterations of ARID1A have been described in CCA, no study has determined whether there are correlations between ARID1A gene mutation and protein expression with clinicopathologic parameters and prognosis, particularly in Ov-CCA. This evidence concerns the gene ARID1A and cholangiocarcinoma.